Kevin Sheth, MD
Neurology · Boston, MANPI 1629184585
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (48.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Biogen accounts for 67.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $12,276 and has fallen 99.8% since, to $29 in 2025.
Across 51 payments — averaging $652.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$22K
- CSL Behring$8K
- Philips North America LLC$2K
- Hyperfine Research, Inc.$632
- Medivance, Inc.$289
- C. R. Bard, Inc. & Subsidiaries$140
- plus $128 from 3 others
Across 30 payments — averaging $39,395 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Hyperfine Operations, Inc.$768K
- Biogen$239K
- Genentech, Inc.$92K
- C. R. Bard, Inc. & Subsidiaries$68K
- ZOLL Circulation Inc$15K
What the payments were for
- Consulting fees$15,49147%
- Travel & lodging$16,27749%
- Food & beverage$1,4964%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 36 | $22,484 |
| CSL Behring | 4 | $8,064 |
| Philips North America LLC | 2 | $1,528 |
| Hyperfine Research, Inc. | 1 | $632 |
| Medivance, Inc. | 3 | $289 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $140 |
| AstraZeneca | 1 | $70 |
| EMD Serono Research & Development Institute, Inc. | 1 | $29 |
| Regeneron | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (82) Healthcare Innovation$1,528
- ARCTIC SUN$169
How this compares
$33,264 in reported general payments places this provider in the 85th percentile of 761 neurology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Boston
- Christopher WrightBoston$2.5M
- Thomas ScammellBoston$617K
- Alfred SandrockBoston$490K
- Pushpa NarayanaswamiBoston$420K
- Roy FreemanBoston$390K
- Michael LevyBoston$387K
- Leeann BurtonBoston$325K
- Ilena GeorgeBoston$316K
- Andrew BudsonBoston$304K
- Denis BalabanBoston$297K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.